An Unbiased View of Molnupiravir
People need to have entirely recovered from your acute toxic consequences of all prior anti-cancer therapy and must fulfill the next bare minimum duration from prior anti-cancer directed therapy ahead of enrollment.Experimental: Dose expansion_sub-population 2_lower dose of niraparib MTDs and/or prospect RP2Ds for elimusertib utilised in combinatio